These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32540979)

  • 1. Efficacy of Guanabenz Combination Therapy against Chronic Toxoplasmosis across Multiple Mouse Strains.
    Martynowicz J; Doggett JS; Sullivan WJ
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540979
    [No Abstract]   [Full Text] [Related]  

  • 2. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation.
    Martynowicz J; Augusto L; Wek RC; Boehm SL; Sullivan WJ
    mBio; 2019 Apr; 10(2):. PubMed ID: 31040237
    [No Abstract]   [Full Text] [Related]  

  • 3. Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis.
    Benmerzouga I; Checkley LA; Ferdig MT; Arrizabalaga G; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6939-45. PubMed ID: 26303803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis.
    Martynowicz J; Sullivan WJ
    Mol Biochem Parasitol; 2021 Sep; 245():111411. PubMed ID: 34492239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts.
    Doggett JS; Schultz T; Miller AJ; Bruzual I; Pou S; Winter R; Dodean R; Zakharov LN; Nilsen A; Riscoe MK; Carruthers VB
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
    Abdelhamid Elgendy WM; Haggag YA; El-Nouby KA; El-Kowrany SI; El Marhoumy SM
    Exp Parasitol; 2023 Mar; 246():108460. PubMed ID: 36642299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Engineered Expression of Mitochondrial Association Factor 1b on
    English ED; Boyle JP
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.
    Montazeri M; Mehrzadi S; Sharif M; Sarvi S; Shahdin S; Daryani A
    Parasitol Res; 2018 Oct; 117(10):3045-3057. PubMed ID: 30088074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis.
    Doggett JS; Nilsen A; Forquer I; Wegmann KW; Jones-Brando L; Yolken RH; Bordón C; Charman SA; Katneni K; Schultz T; Burrows JN; Hinrichs DJ; Meunier B; Carruthers VB; Riscoe MK
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15936-41. PubMed ID: 23019377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of variation in Toxoplasma gondii cyst burden in the murine model.
    Watson GF; Davis PH
    Exp Parasitol; 2019 Jan; 196():55-62. PubMed ID: 30562481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.
    Konrad C; Queener SF; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1815-22. PubMed ID: 23380722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii.
    Djurković-Djaković O; Milenković V; Nikolić A; Bobić B; Grujić J
    J Antimicrob Chemother; 2002 Dec; 50(6):981-7. PubMed ID: 12461021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
    Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
    Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
    Lescano SA; Amato Neto V; Chieffi PP; Bezerra RC; Gakiya E; Ferreira CS; Braz LM
    Rev Soc Bras Med Trop; 2004; 37(6):460-2. PubMed ID: 15765594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Propranolol Effect on Experimental Acute and Chronic Toxoplasmosis Using Quantitative PCR.
    Montazeri M; Ebrahimzadeh MA; Ahmadpour E; Sharif M; Sarvi S; Daryani A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7128-7133. PubMed ID: 27645234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.